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Porcine reproductive and respiratory syndrome virus (PRRSV) is a major economic concern 25 
worldwide. There are currently large data sets available about the ORF5 gene of the virus, with 26 
thousands of sequences available, but little data is currently available on the full-length genome 27 
of PRRSV. We hypothesized that whole genome sequencing (WGS) of PRRSV genome would 28 
allow a better epidemiological monitoring compared to ORF5 gene sequencing. PRRSV PCR 29 
positive sera, oral fluids and tissue clinical samples submitted to the diagnostic laboratory for 30 
routine surveillance or diagnosis of PRRSV infection in Québec, Canada, swine herds were used. 31 
The PRRSV RT-qPCR Cq values of the processed samples varied between 11.5 and 34.34. 32 
PRRSV strain genomes were isolated using a poly(A)-tail method and were sequenced with an 33 
MiSeq Illumina sequencer. Ninety-two full length PRRSV genomes were obtained from 88 34 
clinical samples, out of 132 tested samples, resulting in a PRRSV WGS success rate of 66.67%. 35 
Three important deletions in the ORF1a were found in most wildtype (i.e. not vaccine-like) 36 
strains. The importance of these deletions remains undetermined. Two different full-length 37 
PRRSV genomes were found in four different samples (three sera and one pool of tissues), 38 
suggesting a 4.55% PRRSV strain coinfection prevalence in swine. Moreover, six PRRSV whole 39 
genomes (6.52% of PRRSV strains) were found to cluster differently compared to ORF5 40 
classification method. Overall, WGS of PRRSV enables a better strains classification and/or 41 
interpretation of results in 9.10% of clinical samples compared to ORF5 sequencing, as well as 42 
allowing interesting research avenues. 43 
 44 





Porcine reproductive and respiratory syndrome (PRRS) is a major economic concern 48 
worldwide, costing 663 million dollars yearly to the American swine industry(1) and over 150 49 
million dollars yearly to the Canadian swine industry(2). Part of this cost is due to reproductive 50 
troubles in sow (characterized by late abortion, increased incidence of stillbirth, mummified 51 
fetuses and weaker newborn piglets)(3-6) and retarded growth in piglets, mainly caused by 52 
respiratory problems (characterized by interstitial pneumonia)(5-10) and increased animal 53 
susceptibility to other pathogens(11-13). Beside this direct loss in productivity, a lot of efforts 54 
and resources are allocated to control and contain this infectious disease. Among those efforts, 55 
vaccination and epidemiological surveillance are the most prominent (14, 15). 56 
 57 
The etiological agents of PRRS are one of two viruses of the Arteriviridae family and the 58 
Porartevirus genus that are aptly named porcine reproductive and respiratory syndrome virus 59 
(PRRSV) type 1 and type 2 (officially Betaarterivirus suid 1 and Betaarterivirus suid 2).  Both 60 
PRRSV are enveloped viruses with a diameter of around 50-65 nm(16). They contain a single 61 
stranded positive-sense RNA genome, of around 15 kb in length, capped at the 5’ end and 62 
polyadenylated at the 3’ end and contains at least 11 known open reading frames (ORF)(17, 18). 63 
The first two ORFs (ORF1a and ORF1b), which constitute about 75% of the viral genomes and 64 
contain at least three ribosome shifting sites, encodes replicase polyproteins that are post-65 
translationally cleaved into at least 16 distinct non-structural proteins (nsp) (18-20). The 66 
remaining 25% of the genomes code for at least 8 known structural proteins (GP2, GP3, GP4, 67 
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GP5, M, N, E and GP5a). Both PRRSV species share a nucleotide identity of around 60%(22, 68 
23). 69 
Many genotypes of both PRRSV exist and the virulence of each strain is highly variable. 70 
PRRSV strains found in Canadian swine herds belong to type 2 PRRSV. To our knowledge, 71 
indigenous PRRSV type 1 strains have never been reported in Canada but was found on one 72 
occasion in European imported piglets kept in quarantine. Nine distinct monophyletic lineages of 73 
PRRSV type 2 have been described worldwide. These lineages are genetically distinct, with a 74 
nucleotide (nt) identity between lineage under 89%. Of these 9 lineages, lineage 1, 2, 5 and 8 are 75 
the most prominent in Canada, with lineage 9 showing up sporadically. The vast majority of 76 
lineages 5 and 8 strains are thought to be vaccine related. These lineages have been determined 77 
using Bayesian phylogenies of the ORF5 gene encoding the membrane structural glycoprotein 78 
protein GP5 of the virion. Interestingly, recent studies have investigated the genomic diversity 79 
and relatedness of PRRSV Canadian strains, but all those reports are using PRRSV ORF5 80 
nucleotide sequences into their genomic analyses. However, there is much less information and 81 
data available about the whole viral genome of PRRSV strains both in Canada and around the 82 
globe.  83 
 84 
The inter-strain genetic variability of PRRSV is very high. It is believed that this enables 85 
the virus to better evade the immune system and potentially diminish vaccine efficacy. In an 86 
ongoing effort in Quebec, Canada, as many PRRSV ORF5 sequences as possible are added to an 87 
ever-growing database, with over 4695 ORF5 sequences to date. The goal of this initiative was 88 
to better understand the epidemiological links between various PRRSV strains versus outbreaks 89 
and determine the proximity of a given strain to commercially available vaccinal strains as a 90 
5 
 
strategy to fight PRRS disease. This database is also used to find genetically similar strains, 91 
enabling veterinarians to better predict the severity and outcome of a current outbreak based on 92 
the severity and outcome of past outbreaks with ORF5 genetically similar strains. The Molecular 93 
diagnostic laboratory of the Diagnostic service (Faculté de médecine vétérinaire of Université de 94 
Montréal), is the depository of that Quebec ORF5 sequences databank. The PRRSV ORF5 gene 95 
was selected for the molecular epidemiological surveillance because it was considered 96 
hypervariable and encodes the GP5 protein that acts as the main target of neutralizing antibodies.  97 
 98 
However, the ORF5 is only 603 nucleotides long, representing only 4% of the viral 99 
genome and it has been shown that other genes are also hypervariable and that pathogenicity of 100 
PRRSV is determined by multiple genes. The GP5 antigenicity property (i.e. its recognition by 101 
neutralizing antibodies) has contributed to the selection of ORF5 for PRRSV surveillance despite 102 
the fact that other viral proteins are involved in the virion recognition by neutralizing 103 
antibodies(40). Given the high prevalence of PRRSV infections, concomitant infections with 104 
different strains are expected to occur quite frequently as it is known to happen already in other 105 
swine respiratory viruses. It was previously reported that PRRSV viral recombination occurs 106 
prominently during coinfection with two different strains. All of these facts suggest that in some 107 
clinical cases of PRRSV infections, PRRSV recombinant strains could be misclassified, affecting 108 
the interpretation of the data at hand and the subsequent intervention by veterinarian 109 
practitioners. We thus hypothesized that whole genome sequencing of PRRSV strains from 110 
clinical samples would enable a better classification of PRRSV strains compared to the current 111 
surveillance method of ORF5 sequencing. Therefore, whole genome sequencing of PRRSV 112 
strains could lead to more appropriate interventions by veterinarians and swine producers, in 113 
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addition to improving our understanding of the pathogenicity and the epidemiology of this 114 
important swine pathogen. 115 
  116 
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Material and Methods 117 
 118 
Swine samples.  Convenience swine samples that tested positive for PRRSV type 2 by a RT-119 
qPCR diagnostic assay were selected for whole genome sequencing (WGS) of the entire PRRSV 120 
viral genome.  The samples were submitted to and tested by the «Molecular diagnostic 121 
laboratory (MDL) of Faculté de médecine vétérinaire (FMV), Université de Montréal (UdeM)» 122 
for the identification of PRRSV after an outbreak of the disease in swine herds and to a lesser 123 
extent to conduct surveillance of the virus in swine herds. The PRRSV RT-qPCR diagnostic 124 
assay conducted by MDL (own the American Association of Veterinary Laboratory 125 
Diagnosticians, AAVLD, accreditation) was an in-house assay (protocol: PON-MOL-029). The 126 
swine samples originated from different herds and types of production throughout the province 127 
of Quebec, Canada. Those clinical samples were submitted between December 2015 and 128 
November 2018 (most of them were collected in 2017 [n=62] and 2018 [n=66]). A total of 132 129 
samples were used and included: 70 sera (composed of 43 pooled sera), 2 oral fluids (OF), 32 130 
lungs and 28 pools of tissues (PoT; mainly lungs with several other types of tissues such as 131 
lymph nodes, spleen, liver, intestine, etc.), with PRRSV RT-qPCR diagnostic assay Cq values 132 
between 11.5 and 34.34. The PRRSV viral genome was considered complete if at least 98% of 133 
the coding sequence was obtained.  134 
 135 
Genome extraction and purification.  One hundred mg of lung or PoT were grinded using a 136 
Beadbeater apparatus (model: Mini-Beadbeater-96; BioSpec Products Inc., OK, USA) in PBS, 137 
then centrifuged at full speed for one minute and supernatant was use for viral extraction.  Two 138 
hundred ul of sera and OF were centrifuged for 5 minutes at 10 000 g and supernatant was used 139 
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for viral extraction.  Viral RNA was extracted using Quick-RNA Viral Kit (#R1035, Zymo 140 
Research, CA, USA) as described in the company's protocol.  Thereafter, RNA was eluted using 141 
50 ul of nuclease free water (Corning, NY, USA).  Total elution volume was used to isolate RNA 142 
with poly(A)-tails with a magnetic beads purification method, the NEBNext® Poly(A) mRNA 143 
Magnetic Isolation Module, as described by the company’s protocol, and poly(A)-tails RNA was 144 
resuspended in 15 ul Tris Buffer (#E7490; New England BioLabs, ON, Canada).  Then, first 145 
strand cDNA was synthesised using the Non-directional Reaction Step Up protocol of the 146 
NEBNext® RNA First Strand Synthesis Module (#E7525) (New England BioLabs, ON, 147 
Canada), starting with 10 ul of isolated poly(A)-tails RNA.  Immediately after first strand cDNA 148 
synthesis, the second DNA strand was synthesized using NEBNext® Ultra II Non-Directional 149 
RNA Second Strand Synthesis Module, as described by the manufacturer protocol with a minor 150 
modification at the incubation step in the thermal cycler for 2 hours (instead of 1.5 hours) at 151 
16⁰C (#E6111; New England BioLabs, ON, Canada). dsDNA was then purified using AxyPrep 152 
Mag™ PCR Clean-up Kits (Axygen – Corning, NY, USA) using 1.8X of beads and 70% 153 
ethanol.  The purified dsDNA was diluted in 30 ul of 10mM Tris-HCl at pH 8.0 and stored at -154 
20⁰C for later use. 155 
 156 
PRRSV whole genome sequencing.  dsDNA was quantified using Qubit™ dsDNA HS Assay 157 
Kit and a Qubit™ fluorometer (ThermoFisher Scientific, MA, USA). Sequencing libraries were 158 
prepared using Nextera XT DNA Library Preparation Kit (Illumina, CA, USA). Sequencing 159 
libraries construction were still performed even if the dsDNA quantification results were below 160 
the Qubit™ dsDNA HS Assay Kit threshold of detection (0.2 ng). Briefly, 0.2 to 0.3 ng of 161 
dsDNA were tagmented with 10 µl Tagment DNA Buffer (TD) and 5 µl Amplicon Tagment Mix 162 
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(ATM) at 55°C for 5 minutes, using a Thermocycler TProfessional Basic 96 (Biometra GmbH, 163 
37079 Göttingen, Germany). The transposomes were inactivated with 5 µl of Neutralize 164 
Tagment Buffer (NT). Sequencing libraries were then amplified using index adapter and Nextera 165 
PCR Master Mix (NMP) following those PCR steps: 72°C for 3 minutes, 95°C for 30 seconds; 166 
then 14 cycles of 95°C for 10 seconds, 55°C for 30 seconds, 72°C for 30 seconds; a final 167 
elongation step at 72°C for 5 minutes; and a hold at 10°C until the next step. Sequencing 168 
libraries were then purified using AxyPrep Mag™ PCR Clean-up Kits (Axygen – Corning, NY, 169 
USA) as described by the Nextera XT protocol. Sequencing libraries quality were assessed using 170 
Agilent High Sensitivity DNA Kit with a Bioanalyzer (Agilent, CA, USA). Sequencing libraries 171 
were normalised using LNB1 beads (Nextera XT protocol) or the manual normalisation protocol 172 
if the concentrations of the libraries were on the lower end of the Bioanalyzer curves. 173 
Sequencing libraries were sequenced in a v3 600-cycle cartridge (#MS-102-3003; Illumina) 174 
using an MiSeq Illumina benchtop sequencer (located at the “Veterinary High Throughput 175 
Sequencing Laboratory (VHTSL)”, at FMV) and PhiX was included at around 1% of the total 176 
sequencing libraries, as a control to establish the sequencing run efficacy (Illumina, CA, USA). 177 
 178 
Bioinformatic analyses.  At first, reads were trimmed for adaptors and quality by the MiSeq 179 
software during FastQ generation. Using CLC Genomic Workbench software (version 12.0.3, 180 
Qiagen, CA, USA), reads from a sample were assembled using the software’s built-in de novo 181 
assembly module, including another step of adaptor and quality trimming. Contigs obtained were 182 
checked against a database made using reference type 2 PRRSV genomes available online to 183 
identify the contigs that corresponded to full-length PRRSV sequences. These full-length 184 
genomes obtained by de novo assembly were then added to our PRRSV reference database. 185 
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Secondly, reads from each sample were mapped against the same database. For each sample, the 186 
reference genome onto which the highest number of reads mapped and offered a uniform 187 
coverage was used as the reference genome for resequencing analysis using the software’s map 188 
to reference module. When more then one reference genome seemed to offer an appropriate 189 
depth and coverage, both were used separately for resequencing analysis, and the resulting 190 
sequences compared to one another. Samples from which two PRRSV genomes could be 191 
assembled and possessed a nucleotide (nt) identity of < 96% were considered to contain more 192 
then one PRRSV strain. The < 96% nt identity cut-off value was determined based on the 193 
sequencing error rate of < 1% and the fact that we have ambiguity in less then 1% of the 194 
positions for each complete sequence. Thus, the worst case scenario where both PRRSV 195 
coinfecting strains could each have 1% error rate and 1% uncertainty could lead to identical 196 
strains with a nt identity of ≥ 96%. Therefore, this nt identity value was established as the cut-off 197 
value. PRRSV recombinant status was determined by comparing the location of a given strain’s 198 
individual ORFs on their respective phylogenetic trees. Bioinformatics and data analyses were 199 
performed using the CLC Genomic Workbench software (version 12.0.3, Qiagen, CA, USA). 200 
Phylogenetic trees were constructed using a maximum likelihood model with a type 1 PRRSV 201 
reference strain (Lelystad virus) used as an outgroup and with a bootstrap setting of 1000. The 202 
trees were constructed with the Geneious Prime software (Biomatter, version 2019). 203 
 204 
Accession Numbers 205 
All entire viral genomes of successfully sequenced PRRSV strains were submitted to GenBank 206 
databank, with accession numbers MN865482 to MN865573 (Suppl. Table 1). 207 




PRRSV WGS were obtained from a total of 88 swine clinical samples (an overall 66.67% 210 
PRRSV WGS success rate). In those clinical samples, the PRRSV WGS was successful in two 211 
OF, 13 PoT, 21 lungs and 52 sera. WGS made a difference over ORF5 sequencing in eight of 212 
those samples (Table 1). Ninety-two PRRSV entire genomes were obtained from those clinical 213 
samples (Suppl. Table 1). The additional 4 PRRSV genomes were the consequences of the 214 
identification of 4 PRRSV coinfections, samples in which two different PRRSV strains with a nt 215 
identity below 96% were identified (listed in Table 1). Therefore, a total of 4.55% PRRSV 216 
coinfections were found among PRRSV WGS successful cases. The inter-strains nt identities of 217 
the 92 PRRSV entire viral genome sequences were found to vary between 79.57% and 99.94% 218 
(data not shown). At the viral gene level, the nsp2 and nsp7 encoded genes nt identities were 219 
found to be the least conserved between the 92 PRRSV Quebec strains, with 66.04% and 64.38% 220 
nt identities, respectively, indicating that ORF1a genetic diversity seemingly a little higher 221 
compared to the others ORF. Noteworthy, the overall genetic diversity was scattered throughout 222 
all the ORFs (Fig. 1, Table 2). The highest nt identities were found for the nsp4, E, N and M 223 
gene encoded proteins with 92.41%, 86.94%, 86.13% and 86.10%, respectively.  224 
 225 
Three deletions were identified by WGS in the ORF1a of most wild-type strains (Fig. 1). 226 
The first one, located in the nsp2 coding region at nt positions 2159 to 2491 and is 333 nt long. 227 
The second one, also in the nsp2 coding region, was found around nt positions 2717 to 2773 with 228 
a span of 57 nt. Both deletions occurred together and were found in 63 of the 92 PRRSV Québec 229 
sequenced strains. The third deletion was found in the nsp7 coding region, at position 7106 to 230 
7228 and was 123 nt long. The nt position of the deletions are given relative to the coding 231 
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sequence of the MLV vaccine strain used as a reference. All the strains that harbor the nsp7 232 
deletion also have the nsp2 deletions but some strains that do not possess the nsp7 deletion have 233 
the nsp2 deletions. Only 47 of the 92 sequenced strains have the nsp7 deletions. 234 
 235 
Based on ORF5 sequencing classification method, all 92 PRRSV strains were found to 236 
belong to lineage 1, 5 and 8 (Fig 2b). Interestingly, 18 PRRSV strains were considered to be 237 
MLV vaccine-like strains (i.e. with nt identities > 96%) if the tree was built using ORF5 while 238 
17 strains were considered to be MLV vaccine-like strains while using the whole genome. 239 
Noteworthy, one discrepancy was found in regard to MLV vaccine-like strain relatedness 240 
classification. In fact, PRRSV strain 2072533 was classified as a MLV vaccine-like strain based 241 
on the ORF5 method whereas it was not genetically related to MLV vaccine-like strain based on 242 
WGS results, with nt identities of 98.51% and 84.01%, respectively (Fig. 2). Moreover, PRRSV 243 
strain 2072533 was identified to be a recombinant virus which explains the discrepancy between 244 
the ORF5 and WGS classification methods (Table 1). No difference was found for the ATP 245 
vaccine-like and Fostera vaccine-like classification status (Fig 2a compared to 2b). 246 
Consequently, misclassification by ORF5 sequencing of PRRSV vaccine-like strains was 247 
revealed by WGS in 3.23% of samples. 248 
 249 
As illustrated in Figure 2, PRRSV whole genome sequences phylogenetic tree has 250 
allowed to construct a more robust classification, based on the bootstrap values, compared to the 251 
ORF5 sequencing method. More interestingly, six PRRSV strains (identified by colored arrows 252 
in Fig. 2) were found to cluster differently within the WGS phylogenetic tree compared to the 253 
ORF5 phylogenetic tree. A summary of those classification differences is presented in Table 1. 254 
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One of the reasons that could explain this difference is recombination events, at some point in 255 
time, between two PRRSV strains during coinfection in swine. As an example of this 256 
phenomenon, the 2072533 PRRSV strain nucleotide identity with a presumed parental PRRSV 257 
strain (the MLV vaccine strain) is shown at Figure 3 in which the recombination position was 258 
identified around nt position 12,100. The nt identity between these two PRRSV strains for the 259 
first 12100 nt of the 5’ end (i.e. encompassing ORF1a, ORF1b, ORF2a and ORF2, is 80.46% 260 
whereas it is 98.63% (data not shown) for the 3’ end region of the genome (the last 3,000 nt of 261 
the genome). For strain 1952821 #1, the first half of the genome (mainly the ORF1a) shares a 262 
85.53% nt identity with the MLV vaccine strain, whereas the second half (mostly ORF1b to 263 
ORF7) shares a 96.55% nt identity with the MLV vaccine strain (data not shown), suggesting 264 
again a recombination between a wild-type and vaccine-like strain. For the other possible 265 
recombinant strains, the specific recombination point could not be determined, either because the 266 
parental strains are unknown or because those strains may have undergone several recombination 267 
events over time. Overall, 6.52% possible recombinant viruses over a total of 92 PRRSV strains 268 
were found among PRRSV WGS successful cases. Noteworthy, 2 of the 6 possible recombinant 269 
viruses were found in PRRSV coinfected samples. This is however to be expected given that 270 
coinfection is a prerequisite for recombination events to occur, taking into account that more 271 
then one third of produced virions during coinfections can be PRRSV recombinant viruses(42).  272 
 273 
In four of the 88 successfully sequenced PRRSV positive samples, two different PRRSV 274 
strains were found (Table 1), representing 4.55% coinfections among PRRSV WGS successful 275 
cases as indicated above. The nt identities of these four pairs of PRRSV were 88.8%, 92.36% 276 
91.57% and 81.83% for samples 1890826, 1952821, 1968868 and 2153073, respectively (data 277 
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not shown). A graph of the nucleotide conservation status of the PRRSV strains in sample 278 
2153073 is shown in Figure 4 as an example. Interestingly, the 2153073 #2 strain possesses the 279 
nsp2 and nsp7 deletions like Quebec wildtype strains whereas it’s coinfecting strain, 2153073 280 
#1, is more related to ATP vaccine-like strains (sharing a 99.02% nt identity). All coinfections 281 
were identified from one individual animal (i.e. sample coming from a single animal and not 282 
from a pool of different animals). Interestingly, coinfections were identified in three sera samples 283 
(5.77% of WGS successful sera) and one PoT sample (7.14% of WGS successful PoT) (Suppl. 284 




The first observation that can be easily made from our type 2 PRRSV complete genome 287 
analyses is that many of the PRRSV strains currently circulating in Quebec appear to have three 288 
relatively large deletions (Fig. 1). The first two of these occur in the region coding for the nsp2 289 
protein and the third one in the region coding for the nsp7 protein. While the exact implication of 290 
these deletions is unknown, several investigations have been conducted on type 2 PRRSV strains 291 
possessing various nsp2 deletions, especially with Asian PRRSV strains. The nsp2 protein is 292 
known to play a role in both immune system modulation and pathogenicity. For example, it is 293 
believed that some amino acids in the nsp2 protein could play a role in evading the ubiquitin-294 
ISG15 system of the innate immune response. There are also many reports of highly pathogenic 295 
or epidemic strains recognizable by nsp2 deletions. The importance of nsp2 in the pathogenicity 296 
of PRRSV is what makes these deletions so interesting, and why they warrant further 297 
investigations. Noteworthy, these specific nsp2 deletions can also be found in some PRRSV 298 
strains that were reported in the United States (i.e.: GenBank #KT258000 and #EF532803), 299 
meaning that they are not markers of a specific North American country but are probably 300 
specific to lineage 1 or at least to a subset of lineage 1 PRRSV strains. The involvement of the 301 
third deletion, in the region coding for the nsp7 protein into the pathogenicity of PRRSV, is 302 
much more elusive. PRRSV pathogenicity studies involving nsp7 deletions and mutations 303 
experiment are scarce, and usually involve pinpoint mutations or very short deletions(50). 304 
However, at least one study has reported that nucleotide mutations at some nsp7 specific site 305 
could lead to changes in PRRSV replication efficiency in vitro. Noteworthy, to our knowledge, 306 
this specific nsp7 deletion does not seem to have been previously reported by other investigators. 307 




Overall, the whole genome diversity of PRRSV type 2 strains in Quebec is quite high, as 310 
expected based on ORF5 diversity, with up to 20.43% difference in nucleotide identities between 311 
strains. This diversity is higher in regions coding for proteins considered more or less accessory 312 
and lower for those considered essential, like the polymerase nsp9 or the helicase nsp10, as well 313 
as the structural proteins (Table 2). Interestingly, the most conserved nt encoded protein gene 314 
was found to be the serine protease nsp4 (Table 2), which is the main PRRSV protease 315 
responsible to cleave most of the replicase polyprotein into it’s smaller functional parts(52).  316 
 317 
Type 2 PRRSV WGS classification stays similar for most PRRSV strains compared to 318 
ORF5 classification method which includes 9 lineages. Although, few PRRSV strains appeared 319 
to be of an uncertain lineage when looking at the whole genome sequences. This could be 320 
because WGS may have improve the depth of the genomic analyses compared to ORF5 method 321 
(i.e. 15,000 nt based analyses compared to 603 nt based analyses, respectively). Two examples 322 
of this are the strains 2108698 and 2137004. While both clustered inside the lineage 8 based on 323 
ORF5 phylogenetic tree, they could just as easily be grouped with the reference strain MN30100 324 
of lineage 9 based on whole genome sequencing. Another example of this phenomenon is the 325 
reference strain IAF-klop. We know it belongs to lineage 1, but the whole genome seems to 326 
cluster more closely to the lineages 5-9. Another possible explanation of this is that this specific 327 
strain has been passaged repeatedly in vitro in MARC-145 cell line. Lastly, based on whole 328 
genome sequencing, both strains from the 1890896 sample seem to belong to an uncertain 329 
lineage. The limited availability of PRRSV whole genome sequences data and the relatively 330 
frequent occurrence of viral genome recombination events raise the need to come up with a 331 
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genomic classification system that would take into account the higher variability of some non-332 
structural proteins and the incidence of viral genome recombination events. Such recombination 333 
events pose a real challenge to the current monophyletic lineage classification system.  334 
A more adequate classification of the strains could be made using both the nsp2 and 335 
ORF5 gene sequences in a manner akin to influenza subtyping(54). The nsp2 coding region 336 
seems to routinely contain deletions which can serve as markers of sub-linage as well as being 337 
implicated in pathogenicity, making it a good candidate for typing of different strains (45, 46, 338 
49). WGS remains however the method of choice compared to nsp2/ORF5 sequencing for a few 339 
reasons. Firstly, the nsp2 coding-region is over 3000 nt long and highly variable, making it’s 340 
amplification by PCR for Sanger sequencing quite difficult. Secondly, while adding a second 341 
gene from the 5’ end of the genome would greatly improve odds of catching recombinants, 342 
simply doing a second Sanger sequencing instead of whole genome sequencing would not detect 343 
coinfections in swine samples.  344 
The 4.55% occurrence of PRRSV coinfections amongst PRRSV WGS positive cases was 345 
in line with what has been previously reported for swine influenza virus (SIV). In fact, more then 346 
one subtype (such as H1N1 and H3N2) of SIV are found in at least 2% of the tested samples, not 347 
accounting at all for coinfections with strains from the same subtype(41).  348 
The six possible recombinant PRRSV strains (a prevalence of 6.52%) that cluster 349 
differently, based on WGS analyses, are also of high importance. In the field, veterinarian 350 
practitioners and swine producers are mostly interested in knowing if a strain within a PRRSV 351 
positive sample is genetically related to a PRRSV vaccine-like or wild-type strains, and if it is 352 
related to previous infections on that farm or to other known outbreaks. When a PRRSV strain 353 
changes clustering with WGS, due to a possible recombination event, this can have an important 354 
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impact on the clinical interpretation as it can change its relatedness to a known high or low 355 
pathogenic strain.  356 
From a clinical point of view, the 2072533 strain would have been identified by 357 
veterinarian practitioners, as a MLV vaccine-like strain based on the ORF5 gene method whereas 358 
in fact, it is not a MLV vaccine-like strain based on WGS. Overall, PRRSV WGS has changed 359 
the vaccine-like strain status of one PRRSV strain, i.e. 3.23% of the vaccine-like related cases 360 
(data not shown). 361 
While these analyses have been conducted on Quebec PRRSV strains, there is nothing to 362 
suggest that these findings could not extend to most if not all regions currently affected by 363 
PRRSV type 2 outbreaks as both intra and inter-lineage recombination events have been 364 
described and as coinfections can also occur with type 2 PRRSV strains from the same or 365 
different lineages. These types of recombination events are known to have occurred elsewhere.  366 
The main limit of our current study is that since Canada is exempt of type 1 PRRSV, we 367 
cannot say if these finding also extends to type 1 PRRSV strains. While type 2 PRRSV is the 368 
most frequent PRRSV found in both China and the US, type 1 is also known to occur and data on 369 
the latest is currently limited(57). It is also currently unknown if recombination between both 370 
viral species causing PRRS is possible in a clinical setting. As both species are now becoming 371 
endemic to regions where the other one used to predominate, this could be something to 372 
investigate in the future. It should be noted however that the lack of type 1 PRRSV strains do not 373 
seem to have hindered the Quebec diversity of type 2 PRRSV strains.  374 
To our knowledge, it is the first time that a study has investigated the entire viral genome 375 
of several Canadian PRRSV type 2 strains. In addition to allowing the description of 3 376 
substantial deletions in the ORF1a region of many contemporary lineage 1 strains, WGS appears 377 
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to enable a better interpretation of clinical cases in about 9.10% of PRRSV cases due to either 378 
PRRSV coinfecting strains or the presence of PRRSV recombinant strains. Again, to our 379 
knowledge, it is the first time that both the proportion of misclassifications and the incidence of 380 
coinfections of type 2 PRRSV strains using whole genome sequencing data have been quantified. 381 
In those cases, this additional information (that more then 1 strain was present in a sample or that 382 
the strain is not related to the same strains than those we would have thought with ORF5 383 
sequencing method) could lead directly to more appropriate preventive and palliative measures 384 
being applied by the veterinarians and swine producers, which could have a positive impact in 385 
the overall health of swine herds around the world. 386 
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Table 1: List of clinical samples containing more than one PRRSV strain (coinfection) and 579 


















Both strains clustered differently 
in the same lineage 
1968868 Serum Coinfection 
Both strains clustered differently 
in the same lineage 
2153073 Serum Coinfection 





Strain clustered differently in the 




 Serum Recombinant 
Strain clustered in a different 
lineage compared to ORF5 
method 
1927781 Serum Recombinant 
Strain clustered differently in the 






Strain clustered in a different 
lineage compared to ORF5 
method 
2072533 Serum Recombinant 
Strain clustered in a different 
lineage compared to ORF5 
method 
2087409 Lung Recombinant 
Strain clustered differently in the 
same lineage compared to ORF5 
method 
aAt least two PRRSV different strains were identified in the same clinical sample and were possessing a 
nucleotide identity of < 96%. 
bA PRRSV recombinant status was assigned when a strain clustered more then two nodes away in 
phylogenetic trees based on PRRSV whole genome analysis compared to ORF5 classification method. 
cThe # after the sample identification (id) number represent one of the two PRRSV strains that was 




Table 2: Nucleotide conservation status of the main PRRSV protein encoded genes. The 582 












nsp1 76.15% nsp11 84.01% 
nsp2 66.04% nsp12 82.47% 
nsp3 80.09% GP2 84.70% 
nsp4 92.41% E  86.94% 
nsp5 78.82% GP3 82.35% 
nsp6 77.08% GP4 84.73% 
nsp7 64.38% GP5a 82.05% 
nsp8 82.61% GP5 82.95% 
nsp9 85.75% M 86.10% 
nsp10 84.50% N 86.13% 
aThe highest nucleotide identities obtained between strains were ≥ 99.8% for all protein 
encoded genes. 
 585 




Figure 1: Nucleotide conservation status between Québec PRRSV strains. All 92 PRRSV 588 
sequenced strains are depicted here with the main ORFs shown. Three important and recurrent 589 
deletions in some of the strains are indicated with an *.  The scale to the left of the bar indicates 590 
the percentage of strains that shared identity at a given location, with a full blue bar signifying 591 
that all strains are identical at this position. The numbers on top of the blue bar indicate the 592 





Figure 2: PRRSV whole genome and ORF5 gene nucleotide phylogenetic trees comparison. 596 
A) PRRSV WGS nucleotide phylogenetic tree and B) PRRSV ORF5 nucleotide phylogenetic 597 
tree. The brackets indicate the PRRSV type 2 lineages. MLV, ATP, Fostera, PrimePac and 598 
Prevacent corresponds to commercially available live attenuated vaccines. Strains 97-7895, 599 
MN30100, VR2385 and MN184 are American reference strains. Strain PA8 is the first Canadian 600 
PRRSV whole genome sequenced strain and strain IAF-Klop is a Québec reference strain. The 601 
branches for the Lelystad virus strain (type 1 PRRSV reference strain which was used as an 602 
outgroup) should be three times longer but were shortened to fit the graph. PRRSV coinfecting 603 
strains, i.e. two different strains that were identified in the same clinical samples, are indicated 604 
with a #1 or #2. Colored arrows identify potentially PRRSV recombinant strains that are 605 
clustering differently when WGS and ORF5 phylogenetic trees are compared. The scale bars 606 
represent a 5% difference in nucleotide identity. 607 
  608 
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Figure 3: Comparison of the PRRSV recombinant strain 2072533 with one of its possible 609 
parental strain, the MLV vaccine strain. The red arrow points to the region of the genome 610 
where the recombination probably occurred. A full blue line indicates that both strains are 611 
identical in that given nucleotide position and gray/white indicate that they differ at that position. 612 
The numbers on top of the blue bar indicate the nucleotide position. 613 
  614 
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Figure 4: Nucleotide conservation status of two PRRSV coinfecting strains found in sample 615 
2153073. Nucleotide identity between the two strains found in sample 2153073. A full blue line 616 
indicates that both strains are identical in that given nucleotide position and gray/white indicate 617 
that they differ at that position. The nucleotide identity between both PRRSV strains is 81.83%. 618 
The numbers on top of the blue bar indicate the nucleotide position. 619 





